SBRT Sequential CapeOX Regimen Combined With Bevacizumab and Sintilimab in First-line Treatment of mCRC
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Metastatic Colorectal Cancer
Related studies linked through entity extraction aliases.
Niraparib Maintenance Treatment in mCRC With a Partial o Complete Response After Oxaliplatin-based Induction Therapy
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study of AK112 With or Without AK117 in Metastatic Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Systemic Therapy in Combination with Stereotactic Radiotherapy in Patients with Metastatic Colorectal Cancer Up to 10 Metastatic Sites
- Status
- SUSPENDED
- Phase
- PHASE2
Fruquintinib DDI Study With P-gp and BCRP Substrates
- Status
- COMPLETED
- Phase
- PHASE1
mFOLXOX6 Versus FOLFIRI for Colorectal Patients Recurrence After Oxaplatin Based Adjuvant Chemotherapy
- Status
- UNKNOWN
- Phase
- PHASE3
Study of Magrolimab Given Together With FOLFIRI/Bevacizumab (BEV) in Participants With Previously Treated Advanced Inoperable Metastatic Colorectal Cancer (mCRC)
- Status
- TERMINATED
- Phase
- PHASE2
Triplet (FOLFOXIRI) vs. Doublet (FOLFOX or FOLFIRI) Regimen as a 1st Line Treatment in Metastatic Colorectal Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Nivolumab and Ipilimumab in Anti-PD1-Resistant dMMR/MSI mCRC
- Status
- RECRUITING
- Phase
- PHASE2
Impact of Using the Oncogramme® Device to Select the First Line of Treatment for Patients With Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- NA
CAVE-2 GOIM Study: a Clinical Study of the Combination of Avelumab Plus Cetuximab as Rechallenge Strategy
- Status
- RECRUITING
- Phase
- PHASE2
Chidamide + Celecoxib in Advanced Metastatic Colorectal Cancer (CCmCC)
- Status
- TERMINATED
- Phase
- PHASE1
Trifluridine/Tipiracil (TAS-102) With or Without Thalidomide for the Treatment of Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Irinotecan Plus Anlotinib or Further in Combination With Penpulimab for Second-line Treatment of mCRC
- Status
- RECRUITING
- Phase
- PHASE2
Phase 3 Study of Futuximab/Modotuximab in Combination With Trifluridine/Tipiracil Versus Trifluridine/Tipiracil Single Agent in Participants With Previously Treated Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE3
A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Pembrolizumab and Olaparib in Homologous-recombination Deficient (HRD) Advanced Colorectal Cancer (CRC).
- Status
- UNKNOWN
- Phase
- PHASE2
Evaluation of Efficacy of Trifluridine/Tipiracil Plus an Anti-IL-1α True Human Antibody Versus Trifluridine/Tipiracil Plus Placebo in Metastatic Colorectal Cancer Patients After Failure of Oxaliplatin, Irinotecan, Fluoropyrimidine
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Medical Food for the Dietary Management of Metastatic Colorectal Cancer
- Status
- WITHDRAWN
- Phase
- NA
Resection Observatory
- Status
- COMPLETED
- Phase
- N/A